Velo3D, Inc. (NASDAQ: VELO) operates an at-the-market (ATM) offering program with $50.0M in remaining capacity, representing 7.0% of its current market cap of $715.5M. This level of unused capital-raising authority signals significant dilution risk for shareholders, particularly in a volatile market or if the company accelerates its use of the ATM. Investors must closely monitor how—and when—this program is executed, as aggressive share sales could erode equity value.
An ATM program allows companies to sell shares continuously at market price, providing flexible access to capital. While useful for managing liquidity, such programs often lead to share dilution, which can depress stock prices and reduce earnings per share (EPS). For VELO, the remaining $50M in capacity means the company could, in theory, raise ~7% of its current market cap through new share issuances.
This percentage may seem modest, but dilution risks escalate in two scenarios:
1. Accelerated use: If VELO taps the ATM quickly (e.g., to fund R&D, operations, or strategic initiatives), the market may perceive this as a sign of financial pressure, triggering sell-offs.
2. Price declines: If the stock weakens, the company may be forced to issue more shares to raise the same amount of capital, amplifying dilution. For example, a 20% drop in share price would require ~25% more shares to raise $50M, further eroding ownership.
As a small-cap life sciences/industrial tech company, VELO operates in capital-intensive markets (e.g., additive manufacturing for aerospace and healthcare). While innovation-driven sectors often tolerate dilution for growth, VELO’s market cap of ~$715M leaves little margin for error. A $50M ATM represents ~7% of its total value, a chunky figure for a company that may need to raise additional funds in the future. If VELO’s ATM is renewed or expanded—common practice for biotech and tech firms—the dilution risk compounds.
Investors should focus on three key signals to assess dilution risk:
DilutionWatch monitors shelf registrations, ATM offerings, warrant exercises, and cash runway across thousands of public companies — updated daily from SEC filings.
Get Full Access — Free Trial →